| J0129 | Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 34,430 | $30 | $1.1M |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | 23,380 | $30 | $607.9K |
| J3245 | Injection, tildrakizumab, 1 mg | 4,700 | $110 | $517K |
| J3262 | Injection, tocilizumab, 1 mg | 85,920 | $10 | $429.6K |
| J0717 | Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 94,800 | $1 | $379.2K |
| J0897 | Injection, denosumab, 1 mg | 15,780 | $20 | $284K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 1,090 | $100 | $113.8K |
| J1602 | Injection, golimumab, 1 mg, for intravenous use | 9,770 | $10 | $107.5K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 730 | $90 | $68.1K |
| 96401 | The provider administers nonhormonal, antineoplastic chemotherapy drugs subcutaneously or intramuscularly to the patient. | 740 | $60 | $42K |